Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
Cancer Chemother Pharmacol
; 82(3): 419, 2018 09.
Article
em En
| MEDLINE
| ID: mdl-30014222
The original version of this article unfortunately contained a mistake. The co-authors' names were incorrect.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article